Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves terminal medical institutions, pharmacies, commodity distribution companies, and company franchise stores companies. Shanghai No. 1 Pharmacy Co.,Ltd. was fo… Read more
Market Cap & Net Worth: Shanghai No1 Pharmacy Co Ltd (600833)
Shanghai No1 Pharmacy Co Ltd (SHG:600833) has a market capitalization of $383.10 Million (CN¥2.81 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #15559 globally and #4147 in its home market, demonstrating a 1.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai No1 Pharmacy Co Ltd's stock price CN¥12.60 by its total outstanding shares 223086347 (223.09 Million).
Shanghai No1 Pharmacy Co Ltd Market Cap History: 2015 to 2026
Shanghai No1 Pharmacy Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $578.42 Million to $383.10 Million (-3.37% CAGR).
Shanghai No1 Pharmacy Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai No1 Pharmacy Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Shanghai No1 Pharmacy Co Ltd's market cap is 0.21 times its annual revenue
8.51x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.52x
Shanghai No1 Pharmacy Co Ltd's market cap is 2.52 times its annual earnings
1.86x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $578.42 Million | $1.49 Billion | $41.17 Million | 0.39x | 14.05x |
| 2016 | $591.54 Million | $1.52 Billion | $46.03 Million | 0.39x | 12.85x |
| 2017 | $401.75 Million | $1.56 Billion | $43.48 Million | 0.26x | 9.24x |
| 2018 | $265.48 Million | $1.18 Billion | $47.19 Million | 0.23x | 5.63x |
| 2019 | $275.47 Million | $1.24 Billion | $53.09 Million | 0.22x | 5.19x |
| 2020 | $286.54 Million | $1.59 Billion | $68.54 Million | 0.18x | 4.18x |
| 2021 | $278.45 Million | $1.40 Billion | $49.42 Million | 0.20x | 5.63x |
| 2022 | $338.34 Million | $2.66 Billion | $143.56 Million | 0.13x | 2.36x |
| 2023 | $365.46 Million | $1.82 Billion | $89.28 Million | 0.20x | 4.09x |
| 2024 | $410.46 Million | $1.92 Billion | $163.06 Million | 0.21x | 2.52x |
Competitor Companies of 600833 by Market Capitalization
Companies near Shanghai No1 Pharmacy Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shanghai No1 Pharmacy Co Ltd by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Shanghai No1 Pharmacy Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shanghai No1 Pharmacy Co Ltd's market cap moved from $578.42 Million to $ 383.10 Million, with a yearly change of -3.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥383.10 Million | -2.55% |
| 2025 | CN¥393.13 Million | -4.22% |
| 2024 | CN¥410.46 Million | +12.31% |
| 2023 | CN¥365.46 Million | +8.02% |
| 2022 | CN¥338.34 Million | +21.51% |
| 2021 | CN¥278.45 Million | -2.83% |
| 2020 | CN¥286.54 Million | +4.02% |
| 2019 | CN¥275.47 Million | +3.76% |
| 2018 | CN¥265.48 Million | -33.92% |
| 2017 | CN¥401.75 Million | -32.08% |
| 2016 | CN¥591.54 Million | +2.27% |
| 2015 | CN¥578.42 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shanghai No1 Pharmacy Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $383.10 Million USD |
| MoneyControl | $383.10 Million USD |
| MarketWatch | $383.10 Million USD |
| marketcap.company | $383.10 Million USD |
| Reuters | $383.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.